News Industry News Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events November 02, 2016
News Industry News SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial October 03, 2016
News Industry News SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial June 29, 2015